Manja Kubeil

Dr. Manja Kubeil is a Researcher at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), specializing in radiopharmaceutical chemistry and inorganic coordination chemistry. Her research focuses on developing advanced chelating ligands (e.g., bispidine derivatives) for targeted cancer diagnostics and therapy, with emphasis on isotopes like copper-64, lutetium-177, and actinium-225. She pioneers nanogel-based drug carriers and immunoconjugates for theranostic applications.

Research interests span

• Radiopharmaceutical Development: Designing stable metal complexes for precision oncology.
• Nanomaterial Applications: Utilizing nanogels and nanoparticles for drug delivery and imaging.
• Molecular Targeting: Creating tumor-specific probes for Fibroblast Activation Protein (FAP)-expressing cancers.

Her recent publications demonstrate a strong focus on bispidine ligands for multi-isotope chelation, nanotheranostics, and immuno-PET applications. Collaborative work includes innovations in CAR T-cell therapy integration with radiopharmaceuticals.

No awards, students, or part-time affiliations are documented. Extensive collaborations are evident through co-authorship networks spanning Germany, Italy, and Japan.